Delivering the Added Dimension in Drug Discovery Services
Associate Vice President –
Head DMPK & Toxicology
Dr. Ravi Kumar Trivedi is Ph.D. in Pharmacokinetics with 23 years of drug discovery and development experience in different therapeutic areas with middle and big pharma companies & CROs. He has expertise in ADMET/DMPK with special emphasis on bioanalysis, met ID using newer technologies. He is skilled in design, conduct of rodent and higher species PK and toxicology studies, interpretation of PK parameters, IVIVC, prediction of Human PK along with Human Dose projection. He also brings on board experience in submitting regulatory dossiers.
He started his career with Sun Pharma Advanced Research Centre & later on worked with CRO/Pharma companies; Dr. Reddy’s Labs Ltd., Nektar Therapeutics & Biocon-Bristol Myers Squibb. Before joining Jubilant Biosys, he was associated with Dr. Reddy’s Labs Ltd and led the PK-PD & Bioanalytics work for Biosimilars under Clinical Sciences & Clinical Operations division.
Dr. Ravi received his PhD degree in Pharmaceutical Chemistry from JNT University, Hyderabad. He has a total of around 25 peer reviewed publications, 2 patents in his credit, part of team which launched three biosimilars in emerging market and delivered several oral & poster presentations at various scientific forums.